Baijin Life Science Holdings Limited (HKG:1466)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.520
-0.030 (-5.45%)
Mar 10, 2026, 10:41 AM HKT
4.00%
Market Cap 512.74M
Revenue (ttm) 119.80M
Net Income (ttm) 8.08M
Shares Out 932.25M
EPS (ttm) 0.01
PE Ratio 54.90
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 88,000
Average Volume 156,105
Open 0.520
Previous Close 0.550
Day's Range 0.520 - 0.520
52-Week Range 0.440 - 0.760
Beta -0.11
RSI 55.28
Earnings Date Feb 26, 2026

About HKG:1466

Baijin Life Science Holdings Limited, an investment holding company, engages in the purchase, processing, design, production, assembly, trading, and wholesale distribution of jewelry products. The company operates through three segments: Jewellery Business, Strategic Investment, and Skincare Business. It is involved in the real estate financial assets investment business. The company also offers skincare solutions under the FO brand name; franchise licensing and consultation services; consultation and research and development services; skincare... [Read more]

Industry Luxury Goods
Founded 2014
Employees 79
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 1466
Full Company Profile

Financial Performance

In fiscal year 2025, HKG:1466's revenue was 135.56 million, an increase of 152.54% compared to the previous year's 53.68 million. Losses were -316,000, -95.76% less than in 2024.

Financial Statements

News

There is no news available yet.